February 26, 2020 / 10:43 PM / a month ago

BRIEF-GBT Posts Quarterly Loss Per Share Of $1.59

Feb 26 (Reuters) - Global Blood Therapeutics Inc:

* GBT REPORTS RECENT BUSINESS PROGRESS AND FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* Q4 LOSS PER SHARE $1.59

* Q4 EARNINGS PER SHARE ESTIMATE $-1.24 — REFINITIV IBES DATA

* TOTAL PRODUCT SALES, NET FOR Q4 OF 2019 WAS $2.1 MILLION, DRIVEN BY INITIAL SALES OF OXBRYTA

* GLOBAL BLOOD THERAPEUTICS- CASH, CASH EQUIVALENTS, MARKETABLE SECURITIES TOTALED $695.0 MILLION AT DEC 31, 2019, COMPARED WITH $591.8 MILLION AT DEC 31, 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below